Rich Taylor
Professor
- Office
- 305A Mccourtney Hall
Notre Dame, IN 46556 - Phone
- +1 574-631-5674
- rtaylor@nd.edu
Research Areas
- Organic Chemistry
Research Specialties
- Life Processes
- Medicine
- Synthesis
Prospective Graduate Students
Biography
| Year | Title |
|---|---|
| 2004-present | Professor, University of Notre Dame |
| 2017-2020 | Interim Director of Notre Dame California |
| 2014-2017 | Interim Director of the Warren Family Research Center for Drug Discovery and Development, University of Notre Dame |
| 2013-2016 | Associate Vice President for Research, University of Notre Dame |
| 2008-2013 | Associate Dean, College of Science, University of Notre Dame |
| 2001-2004 | Associate Professor, University of Notre Dame |
| 1995-2001 | Assistant Professor, University of Notre Dame |
| 1992-1995 | Merck Postdoctoral Associate, Stanford University |
| 1992 | Ph.D. in Chemistry, Rensselaer Polytechnic Institute |
| 1987 | B.S. in Chemistry, State University of New York, Oswego |
Selected Awards
2017 University of Notre Dame Faculty Award
2016 Chair of the Gordon Research Conference on Natural Products and Bioactive Compounds
2010 5th Annual Negishi-Brown Lectures, Plenary Speaker
2009 Fellow, American Association for the Advancement of Science
2007 Rev. Edmund P. Joyce Award for Excellence in Undergraduate Teaching
2007 Silveira Distinguished Lecturer, SUNY, Oswego
2002 Kaneb Teaching Award
2001 Eli Lilly Grantee Award
1998 NSF CAREER Award
Research Interests
Chemical and Biological Synthetic Technologies for Accessing Biologically Active Natural Products
Our group is focused on the development of chemical and biological synthetic technologies for the production of natural products and natural product analogues and the study of their therapeutic potential for cancer and rare disease indications. In our lab, chemical synthesis tools such as methodology development and total synthesis are complemented by biological synthesis techniques such as bacterial fermentation, genetic and chemical manipulation, and heterologous expression. The power of synthesis enables access to the complex structures that are the foundation for a medicinal chemistry program.
- Chemical Methodology Development and Total Synthesis
- Bacterial Fermentation and Chemical and Genetic Manipulation of Microorganisms
- Small Molecule Conformational Analysis and Analogue Synthesis
- Biological Assay Development and Screening
Current projects include the development of chemical and biological methods for oxidative processing of putative biosynthetic intermediates towards the anti-cancer natural product, zampanolide and the anti-fungal, cyclopropane-containing polyketide, ambruticin. For several years, our lab has been studying the polyketide natural products, GEX1A and pladienolide, for their potential in rare diseases such as Niemann-Pick Type C and certain rare cancers.
The Identification of New Leads for Rare and Ultra-rare Diseases
Our lab also contributes to several collaborative rare disease programs within the Warren Center for Drug Discovery seeking therapeutic leads for rare indications such as NGly1 deficiency, Cori disease, and Behcet's disease.
Selected Publications
- Umana, C. A.; Henry, J. L.; Saltzman, C. T.; Sackett, D. L.; Jenkins, L. M. and Taylor, R. E. "Linear (-)-Zampanolide: Flexibility in Conformation-Activity Relationships" 2023 ChemMedChem, e202300292. DOI: 10.1002/cmdc.202300292.
- Sellin, M.; Mack, R.; Rhodes, M. C.; Zhang, L.; Berg, S.; Joshi, K.; Liu, S. H.; Wei, W.; Breslin, S.; Larsen, P.; Taylor, R. E. and Zhang, J. W. "Molecular Mechanisms by which Splice Modulator GEX1A Inhibits Leukaemia Development and Progression" 2022 British Journal of Cancer, 227, pp.223-236. DOI: 10.1038/s41416-022-01796-5.
- Lu, S. X.; De Neef, E.; Thomas, J. D.; Sabio, E.; Rousseau, B.; Gigoux, M.; Knorr, D. A.; Greenbaum, B.; Elhanati, Y.; Hogg, S. J.; Chow, A.; Ghosh, A.; Xie, A.; Zamarin, D.; Cui, D.; Erickson, C.; Singer, M.; Cho, H. N.; Wang, E. R.; Lu, B.; Durham, B. H.; Shah, H.; Chowell, D.; Gabel, A. M.; Shen, Y. D.; Liu, J.; Jin, J.; Rhodes, M. C.; Taylor, R. E.; Molina, H.; Wolchok, J. D.; Merghoub, T.; Diaz, L. A.; Abdel-Wahab, O. and Bradley, R. K. "Pharmacologic Modulation of RNA Splicing Enhances Anti-Tumor Immunity" 2021 Cell, 184 (15), pp.4032. DOI: 10.1016/j.cell.2021.05.038.
- Sun, R. C.; Young, L.; Bruntz, R. C.; Markussen, K. H.; Zhou, Z. Q.; Conroy, L. R.; Hawkinson, T. R.; Clarke, H. A.; Stanback, A. E.; Macedo, J.; Emanuelle, S.; Brewer, M. K.; Rondon, A. L.; Mestas, A.; Sanders, W. C.; Mahalingan, K. K.; Tang, B. Y.; Chikwana, V. M.; Segvich, D. M.; Contreras, C. J.; Allenger, E. J.; Brainson, C. F.; Johnson, L. A.; Taylor, R. E.; Armstrong, D. D.; Shaffer, R.; Waechter, C. J.; Vander Kooi, C. W.; DePaoli-Roach, A. A.; Roach, P. J.; Hurley, T. D.; Drake, R. R. and Gentry, M. S. "Brain Glycogen Serves as a Critical Glucosamine Cache Required for Protein Glycosylation" 2021 Cell Metabolism, 33 (7), pp.1404. DOI: 10.1016/j.cmet.2021.05.003.
- Trentadue, K.; Chang, C. F.; Nalin, A. and Taylor, R. E. "Enantioselective Total Synthesis of the Putative Biosynthetic Intermediate Ambruticin J" 2021 Chemistry-a European Journal, 27 (43), pp.11126-11131. DOI: 10.1002/chem.202100975.
- Henry, J. L.; Wilson, M. R.; Mulligan, M. P.; Quinn, T. R.; Sackett, D. L. and Taylor, R. E. "Synthesis, Conformational Preferences, and Biological Activity of Conformational Analogues of the Microtubule-Stabilizing Agents, (-)-Zampanolide and (-)-Dactylolide" 2019 MedChemComm, 10 (5), pp.800-805. DOI: 10.1039/c9md00164f.